| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Bispecific Modeling Framework Enables the Prediction of Efficacy, Toxicity, and Optimal Molecular Design of Bispecific Antibodies Targeting MerTK
|
Li, Ran
|
|
|
26 |
1 |
|
artikel
|
| 2 |
Agreement Between a Colorimetric Assay and Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry for Quantifying Paracetamol Plasma Concentrations
|
Edwina, Angela Elma
|
|
|
26 |
1 |
|
artikel
|
| 3 |
An Explanation of Why Dose-Corrected Area Under the Curve for Alternate Administration Routes Can Be Greater than for Intravenous Dosing
|
Wakuda, Hirokazu
|
|
|
26 |
1 |
|
artikel
|
| 4 |
A Population Model of Time-Dependent Changes in Serum Creatinine in (Near)term Neonates with Hypoxic-Ischemic Encephalopathy During and After Therapeutic Hypothermia
|
Krzyzanski, Wojciech
|
|
|
26 |
1 |
|
artikel
|
| 5 |
Building a Predictive PBPK Model for Human OATP Substrates: a Strategic Framework for Early Evaluation of Clinical Pharmacokinetic Variations Using Pitavastatin as an Example
|
Liang, Xiaomin
|
|
|
26 |
1 |
|
artikel
|
| 6 |
Clinical Bridging Studies and Modeling Approach for Implementation of a Patient Centric Sampling Technique in Padsevonil Clinical Development
|
Kramer, Hester
|
|
|
26 |
1 |
|
artikel
|
| 7 |
Comparison of Two Methods for Determining Item Characteristic Functions and Latent Variable Time-Course for Pharmacometric Item Response Models
|
Arrington, Leticia
|
|
|
26 |
1 |
|
artikel
|
| 8 |
Connexin-Containing Vesicles for Drug Delivery
|
Hanafy, Mahmoud S.
|
|
|
26 |
1 |
|
artikel
|
| 9 |
Correction: A Novel Milli-fluidic Liver Tissue Chip with Continuous Recirculation for Predictive Pharmacokinetics Applications
|
Rajan, Shiny Amala Priya
|
|
|
26 |
1 |
|
artikel
|
| 10 |
Correction to: Immunoinformatic Risk Assessment of Host Cell Proteins During Process Development for Biologic Therapeutics
|
Haltaufderhyde, Kirk
|
|
|
26 |
1 |
|
artikel
|
| 11 |
Design, Synthesis, and Biochemical Analysis of a Molecule Designed to Enhance Endosomal Escape
|
Jadhav, Satish G.
|
|
|
26 |
1 |
|
artikel
|
| 12 |
Development of Quantitative Comparative Approaches to Support Complex Generic Drug Development
|
Gong, Yuqing
|
|
|
26 |
1 |
|
artikel
|
| 13 |
Experience Learned and Perspectives on Using Model-Integrated Evidence in the Regulatory Context for Generic Drug Products—a Meeting Report
|
Tsakalozou, Eleftheria
|
|
|
26 |
1 |
|
artikel
|
| 14 |
Notes on the Use of Kirchhoff’s Laws in Pharmacokinetics
|
Siegel, Ronald A.
|
|
|
26 |
1 |
|
artikel
|
| 15 |
Novel Selective Quantification of Zinpentraxin Alfa Biotherapeutic in the Presence of Endogenous Isomer in Plasma Samples of Idiopathic Pulmonary Fibrosis Patients Using Immunoaffinity LC–MS
|
Li, Maoyin
|
|
|
26 |
1 |
|
artikel
|
| 16 |
Pharmacodynamics of Cyclin D1 Degradation in Ovarian Cancer Xenografts with Repeated Oral SHetA2 Dosing
|
Sharma, Ankur
|
|
|
26 |
1 |
|
artikel
|
| 17 |
Quality of New Domestic Hand Sanitizer Drug Product Manufacturers During COVID-19
|
Stafford, Michelle
|
|
|
26 |
1 |
|
artikel
|
| 18 |
Recommendations for Method Development and Validation of qPCR and dPCR Assays in Support of Cell and Gene Therapy Drug Development
|
Hays, Amanda
|
|
|
26 |
1 |
|
artikel
|
| 19 |
Screening Non-neutralizing Anti-idiotype Antibodies Against a Drug Candidate for Total Pharmacokinetic and Target Engagement Assay
|
Liu, Veronica
|
|
|
26 |
1 |
|
artikel
|
| 20 |
Successful Development of Nonclinical Anti-Drug Antibody Assays to Support Zinpentraxin Alfa Reproductive Toxicology Studies
|
Arjomandi, Audrey
|
|
|
26 |
1 |
|
artikel
|
| 21 |
Taurine, a Naturally Occurring Amino Acid, as a Physical Stability Enhancer of Different Monoclonal Antibodies
|
Sreenivasan, Shravan
|
|
|
26 |
1 |
|
artikel
|
| 22 |
Therapeutic Fusion Proteins
|
Marsh, Morgan C.
|
|
|
26 |
1 |
|
artikel
|
| 23 |
Use of the Same Model or Modeling Strategy Across Multiple Submissions: Focus on Complex Drug Products
|
Walenga, Ross L.
|
|
|
26 |
1 |
|
artikel
|
| 24 |
Using Mechanistic Modeling Approaches to Support Bioequivalence Assessments for Oral Products
|
Wu, Fang
|
|
|
26 |
1 |
|
artikel
|
| 25 |
Virtual Bioequivalence Assessment of Ritlecitinib Capsules with Incorporation of Observed Clinical Variability Using a Physiologically Based Pharmacokinetic Model
|
Saadeddin, Anas
|
|
|
26 |
1 |
|
artikel
|
Tijdschrift beschrijving